Orchid Chemicals gets USFDA nod for Olanzapine Tablets

25 Apr 2012 Evaluate

Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals (Orchid Chemicals) has received an approval from the USFDA for its abbreviated new drug application (ANDA) for Olanzapine Tablets in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths.

Olanzapine tablets are the generic equivalent of Eli Lilly’s Zyprexa tablets. For the twelve months ending December 31, 2011 the total sales for this product in the US were about $3.3 billion.

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Share Price

865.95 0.80 (0.09%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×